International Vaccine Institute Current Affairs

ICMR, Health Ministry ink MoU with IVI for vaccine R&D

The Indian Council of Medical Research (ICMR) and Ministry of Health inked Memorandum of Understanding (MoU) with the International Vaccine Institute (IVI) to collaborate on vaccine research and development.

The signing of the MoU is a continuation of India’s partnership with IVI to provide safe, effective and affordable vaccines for people around the world. With this partnership, India is committing an annual contribution of US $5,00,000 to IVI.

Background

India is a vaccine industry powerhouse that supplies 60% of the world’s vaccines. India has with a long history of scientific collaboration with IVI. IVI has been partnering with Indian vaccine manufacturers, research institutes, government, and public health agencies on vaccine R&D. One of the most successful collaboration of IVI was with India’s Shantha Biotech on development of Shanchol, world’s first low-cost oral cholera vaccine. The vaccine was licensed in India in 2009 and WHO-prequalified in 2011.

International Vaccine Institute (IVI)

IVI is Seoul (South Korea) based international nonprofit organization devoted to developing and introducing new and improved vaccines to protect the people, especially children, against deadly infectious diseases. It was established in 1997 on the initiatives of the United Nations Development Programme (UNDP).

Its work is exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions. Currently, IVI has 40 countries and the World Health Organization (WHO) as signatories to its Establishment Agreement. India officially became a signatory to the IVI in 2012.

Indian Council of Medical Research (ICMR)

The ICMR is India’s apex scientific body for the formulation, coordination and promotion of biomedical research. It was established in 1911 as Indian Research Fund Association (IRFA) making it one of the oldest and largest medical research bodies in the world. The ICMR functions under the Department of Health Research, Union Ministry of Health and Family Welfare.

Tags:

Union Cabinet approves India’s Membership in the International Vaccine Institute

The Union Cabinet has given its approval to the proposal for India’s taking full membership of the International Vaccine Institute (IVI) Governing Council.

This decision involves payment of annual contribution of US $5,00,000 to the IVI (headquartered in Seoul, South Korea).

Background

In 2007 with the approval of Union Cabinet, India joined IVI. Since then India is a long-term collaborator and stake-holder of IVI. In 2012, IVI’s Board of Trustees (BOT) had approved the formation of its new governance structure. As per the new structure of its member state has to contribute to the IVI by paying a portion of its core budget. Since India has been classified in Group-I, it has to pay an annual contribution of US $50,000.

About International Vaccine Institute (IVI)

  • IVI is an international nonprofit organization devoted to developing and introducing new and improved vaccines to protect the people, especially children, against deadly infectious diseases.
  • It was established in 1997 on the initiatives of the United Nations Development Programme (UNDP).
  • Its work is exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.
  • Currently, IVI has 40 countries and the World Health Organization (WHO) as signatories to its Establishment Agreement.

Tags: